ES2118535T3 - Parche que contiene un principio activo. - Google Patents

Parche que contiene un principio activo.

Info

Publication number
ES2118535T3
ES2118535T3 ES95901413T ES95901413T ES2118535T3 ES 2118535 T3 ES2118535 T3 ES 2118535T3 ES 95901413 T ES95901413 T ES 95901413T ES 95901413 T ES95901413 T ES 95901413T ES 2118535 T3 ES2118535 T3 ES 2118535T3
Authority
ES
Spain
Prior art keywords
pct
active substance
body temperature
membrane
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95901413T
Other languages
English (en)
Inventor
Reinhold Meconi
Frank Seibertz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2118535T3 publication Critical patent/ES2118535T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PARCHE CON UN PRINCIPIO ACTIVO PARA SU LIBERACION CONTROLADA, CON UNA CAPA POSTERIOR, UNA CAPA DE ALMACENAMIENTO ADYACENTE QUE CONTIENE PRINCIPIOS ACTIVOS Y QUE SE ABLANDA A LA TEMPERATURA CORPORAL, UNA MEMBRANA QUE REGULA LA LIBERACION DE LOS PRINCIPIOS ACTIVOS, UNA DISPOSICION ADHESIVA QUE POSIBILITA LA FIJACION DEL PARCHE A LA PIEL, Y UNA CAPA PROTECTORA QUE SE PUEDE QUITAR, CARACTERIZADO PORQUE LA CAPA DE ALMACENAMIENTO QUE SE ABLANDA A LA TEMPERATURA CORPORAL ESTA SEPARADA DE LA MEMBRANA REGULADORA POR UN DISPOSITIVO HECHO DE UN MATERIAL QUE NO ES PERMEABLE AL PRINCIPIO ACTIVO, ESTE DISPOSITIVO SE EXTIENDE POR TODAS LAS SUPERFICIES MUTUAMENTE OPUESTAS DE ALMACENAMIENTO Y DE LA MEMBRANA, Y TIENE AL MENOS UN PASO A LA CAPA DE ALMACENAMIENTO QUE SE ABLANDA A LA TEMPERATURA CORPORAL.
ES95901413T 1993-12-04 1994-11-23 Parche que contiene un principio activo. Expired - Lifetime ES2118535T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341444A DE4341444C2 (de) 1993-12-04 1993-12-04 Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ES2118535T3 true ES2118535T3 (es) 1998-09-16

Family

ID=6504235

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95901413T Expired - Lifetime ES2118535T3 (es) 1993-12-04 1994-11-23 Parche que contiene un principio activo.

Country Status (10)

Country Link
US (1) US5770220A (es)
EP (1) EP0731695B1 (es)
JP (1) JP3549888B2 (es)
AT (1) ATE165736T1 (es)
CA (1) CA2177970C (es)
DE (2) DE4341444C2 (es)
DK (1) DK0731695T3 (es)
ES (1) ES2118535T3 (es)
GR (1) GR3027575T3 (es)
WO (1) WO1995015158A1 (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
DE19546024C2 (de) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
JP5334346B2 (ja) * 1999-08-10 2013-11-06 久光製薬株式会社 ロール状外用貼付剤
DE20001165U1 (de) 2000-01-18 2000-03-30 Lichtenberg, Frank-Michael, 12439 Berlin Feuchtpflegetuch
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US6559180B2 (en) 2001-03-27 2003-05-06 Yuri Busiashvili Nitroglycerin-menthol potentiation for treatment of angina
DE10118282A1 (de) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
ATE444773T1 (de) * 2001-04-20 2009-10-15 Alza Corp Mikroprojektionsanordnung mit einem überzug, der ein vorteilhaftes mittel enthält
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
ES2331302T3 (es) 2001-05-01 2009-12-29 A.V. Topchiev Institute Of Petrochemical Synthesis Composiciones de hidrogel.
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
EP1390084B1 (en) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
CA2453013C (en) * 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
KR20060038407A (ko) * 2003-06-30 2006-05-03 알자 코포레이션 비휘발성 반대이온을 포함하는 코팅된 미세돌출부용 제제
EP1648363B1 (en) * 2003-07-03 2019-03-06 Corium International, Inc. Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
US7470266B2 (en) * 2003-09-16 2008-12-30 I-Flow Corporation Fluid medication delivery device
RU2380092C2 (ru) 2004-01-30 2010-01-27 Кориум Интернэшнл, Инк. Быстро растворяющаяся пленка для доставки активного агента
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
EP1791575B1 (en) * 2004-08-05 2014-10-08 Corium International, Inc. Adhesive composition
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP2012504163A (ja) * 2008-09-30 2012-02-16 テイコク ファーマ ユーエスエー インコーポレーテッド 経皮持続送達ドネペジル組成物および該組成物を使用する方法
WO2010083035A2 (en) 2009-01-14 2010-07-22 Corium International, Inc. Transdermal administration of tamsulosin
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
UA112411C2 (uk) 2010-03-26 2016-09-12 Філіп Морріс Продактс С.А. Пригнічення подразнення рецепторів при споживанні бездимних тютюнових виробів
US20140034058A1 (en) * 2011-03-29 2014-02-06 Resmed R&D Germany Gmbh Cushion for patient interface
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3906956B1 (en) * 2013-11-14 2023-10-25 ResMed Pty Ltd A patient interface
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
DE102020214263A1 (de) 2020-11-12 2022-05-12 OPTIMA life science GmbH Vorrichtung und Verfahren zum Übertragen einer Membran
CN113288493A (zh) * 2021-06-24 2021-08-24 蚌埠经济开发区皖美口腔门诊部 一种填充消毒用具

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3503111A1 (de) * 1985-01-31 1986-08-07 Rainer K. Dr. 8022 Grünwald Liedtke Arzneipflaster
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
DE3522060A1 (de) * 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
DE3775830D1 (de) * 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
EP0249475A3 (en) * 1986-06-13 1989-10-11 Alza Corporation Delayed percutaneous delivery
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
US4963261A (en) * 1989-08-28 1990-10-16 Chromex Corp. Microporous membrane having a macroporous support
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset

Also Published As

Publication number Publication date
CA2177970A1 (en) 1995-06-08
ATE165736T1 (de) 1998-05-15
EP0731695A1 (de) 1996-09-18
EP0731695B1 (de) 1998-05-06
GR3027575T3 (en) 1998-11-30
JPH09505815A (ja) 1997-06-10
WO1995015158A1 (de) 1995-06-08
DE4341444C2 (de) 1996-03-14
JP3549888B2 (ja) 2004-08-04
CA2177970C (en) 2006-01-10
DE59405920D1 (de) 1998-06-10
DE4341444A1 (de) 1995-06-08
DK0731695T3 (da) 1999-03-01
US5770220A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
ES2118535T3 (es) Parche que contiene un principio activo.
DK0651635T3 (da) Plaster med aktivt stof til lavtsmeltende og/eller flygtige aktive stoffer
PL329196A1 (en) Transdermal therapeutic system of small thickness and high elasticity and methos of obtaining such system
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
WO2002078602A3 (en) Transdermal delivery of pergolide
DK0689458T3 (da) Plaster med aktiv bestanddel til afgivelse af estradiol på huden
DK0680319T3 (da) Nitroglycerin-holdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf.
DK651089D0 (da) Transdermalt terapeutisk system med norpseudoephedrin som aktiv bestanddel
DK0667774T3 (da) Transdermalt, terapeutisk system til indgivelse af physostigmin genem huden og fremgangsmåde til dets fremstilling
IL114949A0 (en) A transdermal layered therapeutic system containing estradiol and a process for the preparation thereof

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 731695

Country of ref document: ES